These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7452906)

  • 41. Pharmacokinetics of cefroxadine after infusion to healthy volunteers.
    Cadórniga R; Molina IT; Pastoriza P; Negro S; Evora CM; Gutierrez JA
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):435-9. PubMed ID: 2258253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of cefroxadine in pediatrics regarding clinical efficacy and serum levels (author's transl)].
    Iwasaki Y; Iwata S; Kanemitsu T; Jozaki K; Hattori H; Akita H; Hotta M; Yamashita N; Nanri S; Sunakawa K; Oikawa T; Osano M; Ichihashi Y; Kuratsuji T; Haginiwa Y
    Jpn J Antibiot; 1981 Dec; 34(12):1595-603. PubMed ID: 7334584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of loracarbef and interaction with acetylcysteine.
    Roller S; Lode H; Stelzer I; Deppermann KM; Boeckh M; Koeppe P
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):851-5. PubMed ID: 1468429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Administration of cephradine to dermatoses by injection (author's transl)].
    Takahashi H; Kaneko O; Fukuda N
    Jpn J Antibiot; 1976 Nov; 29(11):955-7. PubMed ID: 1003678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory and clinical studies on cefroxadine (author's transl)].
    Nishikawa K; Aso K; Miyachi Y; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1981 Dec; 34(12):1647-54. PubMed ID: 7334589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical phase I study of T-2588].
    Koyama M; Nakagawa K
    Jpn J Antibiot; 1987 Jan; 40(1):55-76. PubMed ID: 3586336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A contribution on the pharmacokinetics of oral cephalosporin antibiotics (author's transl)].
    Dvorácek K; Modr Z; Krebs V
    Cas Lek Cesk; 1976 May; 115(20-21):622-7. PubMed ID: 1277248
    [No Abstract]   [Full Text] [Related]  

  • 48. [The treatment of infectious jaw diseases using oral administration of cefradine: clinical results].
    Marci F; Negri PL; Aliventi F; Nicchiotti L; Orlandi R
    Dent Cadmos; 1985 May; 53(8):81-4. PubMed ID: 3867545
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacokinetics of cephradine suspension infants and children.
    Ginsburg CM; McCracken GH
    Antimicrob Agents Chemother; 1979 Jul; 16(1):74-6. PubMed ID: 475377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of five oral cephalosporins in calves.
    Soback S; Ziv G; Kurtz B; Paz R
    Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic.
    Gower PE; Dash CH
    Br J Pharmacol; 1969 Nov; 37(3):738-47. PubMed ID: 5348475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probenecid and the antibacterial activity of cephradine in vivo.
    Kunst MW; Mattie H
    J Infect Dis; 1978 Jun; 137(6):830-4. PubMed ID: 351091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Talampicillin hydrochloride: Comparison with amoxicillin and ampicillin in the antibacterial activity and pharmacokinetics (author's transl)].
    Tachibana A; Ohtani K; Komiya M; Naito S; Shimizu C; Yano K
    Jpn J Antibiot; 1978 Mar; 31(3):166-76. PubMed ID: 246947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Absorption and excretion in constant infusion of cephaloridine (author's transl)].
    Yamasaku F
    Jpn J Antibiot; 1979 Dec; 32(12):1401-7. PubMed ID: 529422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPLC analysis of cephradine in human serum and urine.
    Clarke GS; Robinson ML
    J Clin Hosp Pharm; 1983 Dec; 8(4):373-4. PubMed ID: 6662974
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative study of serum levels and urinary excretion following oral administration of paromomycin and neomycin (author's transl)].
    Lentzen H; Kölle EU; Daschner F
    Arzneimittelforschung; 1981; 31(11):1967-71. PubMed ID: 7198477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of cefroxadine in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K; Nakamura H
    Jpn J Antibiot; 1981 Dec; 34(12):1663-79. PubMed ID: 7334591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [B.I.D. administration of cephradin in the treatment of cystitis and pyelonephritis (author's transl)].
    Ruiloba J; Palacios GR
    Rev Invest Clin; 1977; 29(2):137-41. PubMed ID: 331425
    [No Abstract]   [Full Text] [Related]  

  • 60. Peroral absorption of cefroxadine in patients within the first day after severe trauma: comparison to cefroxadine pharmacokinetics in fasted, healthy volunteers.
    Beyssac E; Ritschel WA; Aiache JM; Haberer JP
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):565-72. PubMed ID: 1956212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.